UiPath (PATH) In-Depth Stock Report
A full valuation and forecasting workup on UiPath, the enterprise robotic process automation (RPA) pioneer pivoting toward AI-powered automation agents amid decelerating core growth and intensifying competition from ServiceNow and SAP. Every number below is computed live from BriMindInvest's own data pipeline, not copied from a template.
Investment Summary
Every headline number this report produces, collected in one place before the analysis that derives them. All figures are computed live at page load, so this block reflects the market as of the moment you opened the page.
- Seven independent intrinsic-value methods run live against current financials, with an implied upside/downside versus the current price.
- A proprietary six-factor AI Score (value, growth, profitability, health, momentum, risk) percentile-ranked against our full coverage universe.
- A blended 1-year price target combining our internal model with live Wall Street analyst consensus.
- A 5-year Monte Carlo simulation built from 2,000 bootstrap paths over UiPath's own historical monthly returns — a probability band, not a single guess.
- A structured bull case, bear case, catalyst list, and risk register written specifically for this report.
- A breakdown of UiPath's core Robotic Process Automation (RPA) platform, its Agentic Automation/AI agent offerings, and its enterprise subscription and net-retention dynamics.
- Live analyst rating distribution, institutional ownership breakdown, quarterly EPS beat/miss history, and multi-year revenue and net income — pulled directly from aggregated sell-side and financial-statement data.
Executive Summary
UiPath (NYSE: PATH) is a leading provider of enterprise robotic process automation (RPA) software, historically helping large organizations automate repetitive, rules-based digital tasks across finance, operations, and IT workflows.
The company's revenue growth has decelerated meaningfully from its earlier hyper-growth years as the core RPA market matures and enterprise customers scrutinize software spending more closely, pressuring net new annual recurring revenue (ARR) additions.
UiPath is pivoting its product strategy toward agentic automation, combining traditional RPA with AI-powered autonomous agents capable of more complex, judgment-based decision-making, positioning the company for the broader enterprise AI-agent opportunity.
Competition has intensified from platform vendors including ServiceNow and SAP, both of which have added automation and AI-agent capabilities to their broader enterprise software suites, pressuring UiPath's historically standalone RPA positioning.
This report walks through UiPath's live valuation across seven independent methods, its proprietary AI Score, a blended analyst price target, and a 5-year Monte Carlo simulation — then lays out the bull case, bear case, and the specific catalysts and risks most likely to move the stock, with particular attention to net new ARR trends and agentic-automation product adoption.
Industry & Market Backdrop
The broader competitive and macro environment PATH operates in — context a pure valuation table can't convey on its own.
The robotic process automation (RPA) industry has matured significantly from its earlier hyper-growth phase, as most large enterprises have already piloted or adopted foundational automation for common workflows, shifting the growth opportunity toward more complex use cases.
Generative AI and AI-agent technology have reshaped the competitive landscape for automation software, with vendors racing to combine traditional rules-based RPA with more autonomous, judgment-capable AI agents.
Large enterprise software platforms, including ServiceNow, SAP, and Microsoft, have increasingly embedded automation and AI-agent capabilities into their broader suites, pressuring the market position of standalone automation vendors like UiPath.
Enterprise software buyers have become more disciplined in evaluating return on investment for automation initiatives, extending sales cycles and increasing scrutiny on renewal and expansion spending industry-wide.
Live Key Statistics
Pulled live from BriMindInvest's market-data pipeline at page load — the same feed that powers /analysis/PATH. Fields the pipeline doesn't return this load are omitted rather than shown blank.
Business Overview
UiPath generates revenue primarily through subscription licenses for its RPA and agentic-automation platform, sold to large and mid-sized enterprises, with growth historically driven by both new-customer acquisition and expansion within the existing base.
Growth strategy centers on transitioning customers toward its agentic automation and AI-agent offerings, improving net-retention trends, and defending its enterprise automation positioning against platform competitors like ServiceNow and SAP.
Segment Deep Dive
A closer look at each reporting segment individually, rather than treating the business as a single undifferentiated revenue line.
UiPath's founding product category, automating repetitive, rules-based digital tasks across enterprise workflows, now a maturing business facing deceleration as most large customers have already completed initial automation deployments.
UiPath's strategic pivot toward AI-powered autonomous agents capable of more complex, judgment-based decision-making beyond traditional rules-based RPA, representing the company's primary growth vector and competitive response to the broader enterprise AI-agent wave.
UiPath's broader automation-management platform, including orchestration, process mining, and governance tools that allow large enterprises to manage automation and AI-agent deployments at scale across business units.
Capital Allocation & Balance Sheet Philosophy
How management has historically chosen to deploy cash — buybacks, dividends, R&D, and acquisitions — and what that reveals about capital discipline.
UiPath does not pay a dividend, instead prioritizing reinvestment in agentic-automation product development and periodic share buybacks funded by free cash flow.
Capital spending priorities include continued AI-agent research and development, sales-and-marketing investment to drive the platform transition, and selective tuck-in acquisitions.
The company maintains a strong balance sheet with substantial cash reserves and limited debt, providing flexibility to invest through the current growth-deceleration period.
Management & Governance
Leadership, incentive alignment, and governance structure — factors that shape execution risk independent of the underlying business model.
UiPath's leadership has prioritized the transition toward agentic automation and AI-agent capabilities as the central strategic response to decelerating core RPA growth and intensifying platform competition.
Prospective investors should review the company's most recent proxy statement and 10-K for current board composition, executive compensation structure, and insider ownership details, since these are disclosed directly by the company and evolve over time rather than being estimated by third parties.
See exactly how we get PATH's fair-value range
Forecast Revenue and Free Cash Flow
5-Year Monte Carlo Simulation
Included with a subscription or a one-time purchase of this UiPath report:
- Fair value from 7 methods, weighted by relevance to this business
- 5-year financial forecast and DCF/earnings sensitivity grids
- Decomposed AI Score, Monte Carlo simulation, and institutional/analyst data
$3.99 is less than one bad options trade — see the model before you commit real money.
Bull Case vs. Bear Case
- UiPath's deep, purpose-built automation platform and established enterprise relationships provide a foundation for transitioning existing customers toward agentic automation.
- A strong balance sheet with substantial cash reserves and limited debt provides flexibility to invest through the current growth-deceleration period.
- The broader enterprise AI-agent opportunity could reaccelerate growth if UiPath's agentic automation products gain meaningful adoption.
- Consistent free cash flow generation supports continued R&D investment and share buybacks without reliance on external financing.
- Current valuation, following the stock's substantial decline from its post-IPO highs, may already reflect much of the growth-deceleration and competitive risk.
- Core RPA revenue growth has decelerated meaningfully as the market matures and most large enterprises have completed initial automation deployments.
- Intensifying competition from ServiceNow and SAP, both embedding automation and AI-agent features into broader platforms, threatens UiPath's standalone market position.
- Net new annual recurring revenue additions have slowed, reflecting both a maturing core market and more disciplined enterprise software buying behavior.
- The agentic-automation product transition remains unproven at scale, and could take longer than expected to meaningfully reaccelerate growth.
- Extended enterprise sales cycles and increased ROI scrutiny industry-wide could continue to pressure new-business growth.
Related Reports
In-depth reports for other names in UiPath's comparable set.
5 catalysts and 5 risks we're tracking for PATH
| Catalyst | Expected Impact | Timeframe |
|---|---|---|
Included with a subscription or a one-time purchase of this UiPath report:
- Catalyst list, each tagged with expected impact and timing
- Risk register scored by probability and severity
- 4 key metrics to watch before the next earnings report
$3.99 is less than one bad options trade — see the model before you commit real money.
What Would Change Our Mind?
Specific, falsifiable triggers — not vague sentiment — that would move us toward or away from the bull case above.
- Net new ARR stabilizing or reaccelerating on agentic automation adoption.
- Net revenue retention improving, signaling stronger expansion within existing customers.
- Agentic automation products gaining meaningful enterprise traction faster than expected.
- Continued strong free cash flow supporting sustained R&D investment and buybacks.
- Net new ARR continuing to decline as the core RPA market matures further.
- ServiceNow or SAP winning a meaningfully larger share of enterprise automation budgets.
- Agentic automation products failing to gain traction despite continued investment.
- Net revenue retention declining further amid extended enterprise sales cycles.
Competitive Positioning
ServiceNow competes with UiPath by embedding automation and AI-agent capabilities within its broader IT service management and workflow-automation platform, leveraging its large existing enterprise customer base.
SAP competes with UiPath through its own automation and AI-agent offerings embedded within its enterprise resource planning ecosystem, particularly among large multinational customers.
Monday.com competes at the margins through its own workflow-automation and work-management platform, though its focus and target customer base differ meaningfully from UiPath's enterprise RPA core.
UiPath's deep, purpose-built automation platform and established enterprise customer relationships provide a competitive advantage in complex, large-scale automation deployments relative to point-solution or bundled-feature competitors.
Investor Decision Framework
A process for using this report, not a recommendation — how to weigh valuation, scenario spread, and your own risk tolerance.
- This section is educational, not a personalized recommendation — it is a framework for organizing your own analysis, not an instruction to buy or sell UiPath.
- A central judgment call for this stock is whether agentic automation and AI-agent adoption can reaccelerate growth faster than the core RPA business decelerates.
- Consider tracking quarterly net new ARR and net revenue retention disclosures as the clearest real-time signals of the platform transition's success.
- Weigh UiPath's deep automation platform and enterprise relationships against intensifying competition from ServiceNow and SAP embedding automation into broader suites.
- Revisit the thesis with each quarterly earnings release, paying particular attention to net new ARR growth and agentic automation adoption commentary.
- Cross-check this report's live analyst rating distribution and consensus price target against your own view.
The BriMindInvest Edge
Why this report is different from asking a general-purpose AI chatbot about the stock.
- Every valuation number on this page is computed live from current market data through our own DCF, scoring, and Monte Carlo engines — not summarized or paraphrased from other analysts' reports the way a general chatbot would.
- The relevance-weighted fair value, reverse-DCF market-implied growth, fundamentals-based Monte Carlo, and scenario tables above are proprietary calculations you cannot get by asking a general-purpose AI for "PATH fair value" — those answers come from web summaries of other people's price targets, not a live, disclosed-assumption model.
- Our 1-year price-target model has a real, published backtest (see Model Track Record above where covered) — we show our work and our error rate rather than asserting accuracy.
- Numbers here are refreshed every time you load the page, not cached from a training cutoff months or years in the past.
Data Sources & Methodology
Valuation, price, and financial-statistics data in this report are fetched live from our production market-data pipeline (Yahoo Finance and Finnhub) at the time you loaded this page. The AI Score is a percentile ranking against our full covered stock universe, recomputed nightly. The fundamentals-based Monte Carlo and Bull/Base/Bear scenarios randomize growth rate, discount rate, and terminal growth around the same disclosed DCF assumptions used in the valuation table — they are not derived from resampled historical stock returns. The secondary historical-volatility simulation (2,000 bootstrap paths, seeded for reproducibility) uses the stock's own historical monthly returns and is shown separately because it measures a different thing (volatility) than the fundamentals-based model (intrinsic value).
This report is for informational and educational purposes only and does not constitute financial, investment, or tax advice, or a recommendation to buy or sell any security. All valuation models, price targets, and simulations are estimates based on historical and current data; actual results will differ, potentially substantially. Investing involves risk, including loss of principal. See our full Methodology and Disclaimer.
Free vs. Premium: What You're Getting
- Narrative overview and general bull/bear framing
- Headline price and basic company facts
- No live valuation model, AI Score, or forecast table
- Relevance-weighted fair value range and reverse-DCF market-implied growth
- 5-year financial forecast, DCF sensitivity grid, and Bull/Base/Bear scenario table
- Fundamentals-based Monte Carlo and decomposed AI Score with sub-factor components
- Real, published backtested accuracy where PATH is in our coverage set
Glossary of Key Terms
Plain-English definitions for the terms used throughout this report, for readers newer to equity valuation.
Frequently Asked Questions
Unlock Full AI-Powered Analysis
Get AI prediction signals, unlimited stock comparisons, portfolio analytics, and personalized watchlists — free for 14 days, no credit card required.
14-day free trial · No credit card required · Cancel anytime